Skip to main content

Biotecon, Biotest Ink Sales Pact for PCR Pathogen Testing

NEW YORK (GenomeWeb News) – Biotest will distribute Biotecon Diagnostics' real-time PCR-based testing system for identifying microorganisms under a new, global sales agreement, Biotecon said today.

Beginning in September, Biotest's global microbiology business unit will sell Biotecon's Hygiene Screening System, which can identify Staphylococcus, Micrococcus, Kocuria, and Kytococcus in under two hours from a single bacterial colony, Biotecon said.

The company will market the system to customers in the pharmaceutical and environmental monitoring industries.

"Our customers in the pharmaceutical industry will benefit from this rapid microbiology method for the identification of bacterial colonies grown on our solid media, which are optimized for monitoring tests," Frank Schulze, executive VP of Biotest's global microbiology business unit, said in a statement.

Biotecon is based in Potsdam, Germany, and Biotest is based in Eppelheim, Germany.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.